Showing results (21-30 of 346) with videos related to

Sort By:
Pageof 35
International Journal of Oncology|May 17, 2011
Treatment of locally advanced squamous-cell carcinoma of the head and neck with concurrent radiochemotherapy - randomized comparison of Cisplatin versus CarboplatinG Gasparini, A Testolin, S Maluta, et al.
Growth Regulation|December 1, 1992
PC-10 antibody to proliferating cell nuclear antigen (PCNA) is not related to prognosis in human breast carcinomaG Gasparini, S Meli, F Pozza, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|April 1, 1994
Histomorphological analysis of the effect of rigid fixation on growing sutures in the rabbitF Carinci, D Zaffe, A Pagliarini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
The combined evaluation of p53 accumulation and of Ki-67 (MIB1) labelling index provides independent information on overall survival of ovarian carcinoma patientsG Viale, P Maisonneuve, E Bonoldi, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|May 1, 1989
[Surgery of the base of the skull]A Mazzoni, R Pareschi, M Sanna, et al.
Breast Cancer Research and Treatment|January 1, 1994
A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinomaG Gasparini, P Boracchi, P Bevilacqua, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancerG Gasparini, F Pozza, R Dittadi, et al.
Anticancer Research|November 1, 1991
Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressivenessG Gasparini, F Pozza, S Meli, et al.
Anticancer Research|July 1, 1991
Relationship of the epidermal growth factor-receptor to the growth fraction (Ki-67 antibody) and the flow cytometric S-phase as cell kinetics parameters, in human mammary carcinomasG Gasparini, M Reitano, P Bevilacqua, et al.
International Journal of Oncology|May 18, 2011
Multivariate-analysis of prognostic factors in 232 patients with clinical stage-I endometrial adenocarcinoma using the new figo surgical staging systemG Gasparini, R Sposetti, F Pozza, et al.
Pageof 35